SkinHealth Systems Statistics
Total Valuation
SKIN has a market cap or net worth of $86.60 million. The enterprise value is $249.01 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SKIN has 129.60 million shares outstanding. The number of shares has increased by 2.20% in one year.
| Current Share Class | 129.60M |
| Shares Outstanding | 129.60M |
| Shares Change (YoY) | +2.20% |
| Shares Change (QoQ) | +3.11% |
| Owned by Insiders (%) | 9.13% |
| Owned by Institutions (%) | 47.51% |
| Float | 65.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.28 |
| Forward PS | 0.28 |
| PB Ratio | 1.52 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2.96 |
| P/OCF Ratio | 2.91 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 17.86, with an EV/FCF ratio of 8.75.
| EV / Earnings | n/a |
| EV / Sales | 0.84 |
| EV / EBITDA | 17.86 |
| EV / EBIT | n/a |
| EV / FCF | 8.75 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 6.65.
| Current Ratio | 1.79 |
| Quick Ratio | 1.43 |
| Debt / Equity | 6.65 |
| Debt / EBITDA | 19.11 |
| Debt / FCF | 12.90 |
| Interest Coverage | -0.46 |
Financial Efficiency
Return on equity (ROE) is -11.95% and return on invested capital (ROIC) is -4.93%.
| Return on Equity (ROE) | -11.95% |
| Return on Assets (ROA) | -1.15% |
| Return on Invested Capital (ROIC) | -4.93% |
| Return on Capital Employed (ROCE) | -3.33% |
| Weighted Average Cost of Capital (WACC) | 5.99% |
| Revenue Per Employee | $483,067 |
| Profits Per Employee | -$10,675 |
| Employee Count | 613 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 1.83 |
Taxes
In the past 12 months, SKIN has paid $2.51 million in taxes.
| Income Tax | 2.51M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.27% in the last 52 weeks. The beta is 1.12, so SKIN's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -64.27% |
| 50-Day Moving Average | 0.96 |
| 200-Day Moving Average | 1.44 |
| Relative Strength Index (RSI) | 36.06 |
| Average Volume (20 Days) | 1,203,964 |
Short Selling Information
The latest short interest is 15.65 million, so 12.08% of the outstanding shares have been sold short.
| Short Interest | 15.65M |
| Short Previous Month | 15.36M |
| Short % of Shares Out | 12.08% |
| Short % of Float | 24.08% |
| Short Ratio (days to cover) | 25.72 |
Income Statement
In the last 12 months, SKIN had revenue of $296.12 million and -$6.54 million in losses. Loss per share was -$0.15.
| Revenue | 296.12M |
| Gross Profit | 192.22M |
| Operating Income | -10.58M |
| Pretax Income | -3.55M |
| Net Income | -6.54M |
| EBITDA | 13.94M |
| EBIT | -10.58M |
| Loss Per Share | -$0.15 |
Full Income StatementBalance Sheet
The company has $202.36 million in cash and $367.13 million in debt, with a net cash position of -$164.77 million or -$1.27 per share.
| Cash & Cash Equivalents | 202.36M |
| Total Debt | 367.13M |
| Net Cash | -164.77M |
| Net Cash Per Share | -$1.27 |
| Equity (Book Value) | 55.24M |
| Book Value Per Share | 0.43 |
| Working Capital | 122.49M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $28.94 million and capital expenditures -$482,000, giving a free cash flow of $28.45 million.
| Operating Cash Flow | 28.94M |
| Capital Expenditures | -482,000 |
| Depreciation & Amortization | 24.52M |
| Net Borrowing | -193.52M |
| Free Cash Flow | 28.45M |
| FCF Per Share | $0.22 |
Full Cash Flow StatementMargins
Gross margin is 64.91%, with operating and profit margins of -3.57% and -2.04%.
| Gross Margin | 64.91% |
| Operating Margin | -3.57% |
| Pretax Margin | -1.20% |
| Profit Margin | -2.04% |
| EBITDA Margin | 4.71% |
| EBIT Margin | -3.57% |
| FCF Margin | 9.61% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.20% |
| Shareholder Yield | -2.20% |
| Earnings Yield | -7.77% |
| FCF Yield | 33.78% |
Analyst Forecast
The average price target for SKIN is $1.90, which is 184.35% higher than the current price. The consensus rating is "Buy".
| Price Target | $1.90 |
| Price Target Difference | 184.35% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 14.22% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SKIN has an Altman Z-Score of -0.41 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.41 |
| Piotroski F-Score | 5 |
